摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3β-acetoxy-5β-pregn-14-en-20-one | 18221-13-1

中文名称
——
中文别名
——
英文名称
3β-acetoxy-5β-pregn-14-en-20-one
英文别名
3beta-Acetoxy-5beta-pregn-14-en-20-one;[(3S,5R,8R,9S,10S,13R,17S)-17-acetyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
3β-acetoxy-5β-pregn-14-en-20-one化学式
CAS
18221-13-1
化学式
C23H34O3
mdl
——
分子量
358.521
InChiKey
JUAATDNYHZEPLN-FCFLTHKLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    452.9±45.0 °C(Predicted)
  • 密度:
    1.09±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.7
  • 重原子数:
    26
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3β-acetoxy-5β-pregn-14-en-20-one 在 sodium cyanoborohydride 、 溶剂黄146对甲苯磺酰肼 、 zinc(II) iodide 作用下, 生成 3β-acetoxy-5β-pregn-14-ene
    参考文献:
    名称:
    A New Approach to the Design of Novel Inhibitors of Na+,K+-ATPase:  17α-Substituted Seco-D 5β-Androstane as Cassaine Analogues
    摘要:
    A new three-dimensional model for the relative binding mode of cassaine 1 and digitoxigenin 2 at the digitalis receptor site is proposed on the basis of the structural and conformational similarities among 1, 2 and its 14,15-seco analogues 3 and 4. Accordingly, the speculation that also 17 alpha-substituted derivatives of the digitalis 5 beta,14 beta-androstane skeleton could efficiently bind to the Na+,K+-ATPase receptor is put forward and verified through the synthesis of some related compounds. The binding affinity shown by 2-(N,N-dimethylamino)ethyl 3 beta,14-dihydroxy-5 beta,14 beta-androstane-17 alpha-acrylate 6 (IC50 = 5.89 mu M) and, much more significantly, by the corresponding 14,15-seco-14-oxo derivative 9 (IC50 = 0.12 mu M) substantiates the new hypothesis and opens new prospects to the design of novel inhibitors of Na+,K+-ATPase as potential positive inotropic compounds.
    DOI:
    10.1021/jm980108d
  • 作为产物:
    描述:
    Sioraside吡啶盐酸溶剂黄146 作用下, 以 为溶剂, 反应 9.0h, 生成 3β-acetoxy-5β-pregn-14-en-20-one
    参考文献:
    名称:
    A pregnane glycoside from Streblus asper
    摘要:
    DOI:
    10.1016/0031-9422(92)80075-p
点击查看最新优质反应信息

文献信息

  • Studies on the synthesis of cardiotonic steroids. I. Efficient synthesis of cardenolides.
    作者:EIICHI YOSHII、TORU KOIZUMI、HIROKAZU IKESHIMA、KYUICHI OZAKI、ICHIHIRO HAYASHI
    DOI:10.1248/cpb.23.2496
    日期:——
    Practical synthetic methods of natural cardenolides are illustrated in the syntheses of xysmalogenin and digitoxigenin. The new routes employ pregn-14-en-20-one as key intermediate which was prepared by partial reduction of 14, 16-dien-20-one with triphenylstannane or triethylsilane. A general and efficient method was devised for obtaining cardenolides consisting of (1) 21-methylsulfenylation of pregnen-20-one, (2) the reaction of the resulting 21-methylthio derivative with bromoacetate and zinc, (3) alumina chromatography of epoxy ester obtained from the S-methylated Reformatsky product.
    天然卡登诺酮的实用合成方法在xysmalogenin和digitoxigenin的合成中得到了展示。这些新路线使用孕苯-14-烯-20-酮作为关键中间体,该中间体通过用三苯基或三乙基硅烷对14, 16-二烯-20-酮进行部分还原制备。设计了一种通用且高效的方法来获得卡登诺酮,包括:(1)孕烯-20-酮的21-甲基亚酰化;(2)将得到的21-甲基生物溴乙酸酯和反应;(3)对从S-甲基化Reformatsky产物中获得的环氧酯进行铝土矿柱层析。
  • Seco-d steroids active on the cardiovascular system, processes for their
    申请人:Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    公开号:US05955632A1
    公开(公告)日:1999-09-21
    New seco-D steroid derivatives, processes for their preparation and pharmaceutical compositions are provided, which are active on the cardiovascular system. The seco-D steroid derivatives have the following general formula (I): ##STR1##
    本发明提供了新的seco-D类类固醇生物、其制备方法和药物组合物,其对心血管系统具有活性。这些seco-D类类固醇生物具有以下通式(I):##STR1##
  • Theil, Fritz; Lindig, Claus; Repke, Kurt, Zeitschrift fur Chemie, 1980, vol. 20, # 10, p. 372 - 373
    作者:Theil, Fritz、Lindig, Claus、Repke, Kurt
    DOI:——
    日期:——
  • New seco-D steroids active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
    申请人:SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A.
    公开号:EP0825177B1
    公开(公告)日:2000-04-05
  • US5955632A
    申请人:——
    公开号:US5955632A
    公开(公告)日:1999-09-21
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B